AU2016348841B2 - Composition comprising Lactobacillus plantarum 2830 (ECGC 13110402) - Google Patents
Composition comprising Lactobacillus plantarum 2830 (ECGC 13110402) Download PDFInfo
- Publication number
- AU2016348841B2 AU2016348841B2 AU2016348841A AU2016348841A AU2016348841B2 AU 2016348841 B2 AU2016348841 B2 AU 2016348841B2 AU 2016348841 A AU2016348841 A AU 2016348841A AU 2016348841 A AU2016348841 A AU 2016348841A AU 2016348841 B2 AU2016348841 B2 AU 2016348841B2
- Authority
- AU
- Australia
- Prior art keywords
- composition
- lactobacillus plantarum
- use according
- hypertension
- ecgc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1519327.9 | 2015-11-02 | ||
| GBGB1519327.9A GB201519327D0 (en) | 2015-11-02 | 2015-11-02 | Composition |
| PCT/GB2016/053390 WO2017077286A1 (en) | 2015-11-02 | 2016-11-02 | Composition comprising lactobacillus plantarum 2830 (ecgc 13110402) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2016348841A1 AU2016348841A1 (en) | 2018-04-26 |
| AU2016348841B2 true AU2016348841B2 (en) | 2023-11-16 |
Family
ID=55130540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2016348841A Active AU2016348841B2 (en) | 2015-11-02 | 2016-11-02 | Composition comprising Lactobacillus plantarum 2830 (ECGC 13110402) |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11413317B2 (enExample) |
| EP (1) | EP3370747B1 (enExample) |
| JP (1) | JP6867378B2 (enExample) |
| AU (1) | AU2016348841B2 (enExample) |
| CA (1) | CA3001539A1 (enExample) |
| GB (1) | GB201519327D0 (enExample) |
| WO (1) | WO2017077286A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201319540D0 (en) * | 2013-11-05 | 2013-12-18 | Optibiotix Health Ltd | Composition |
| GB201719480D0 (en) * | 2017-11-23 | 2018-01-10 | Optibiotix Ltd | Compositions |
| JP7007644B2 (ja) * | 2017-12-13 | 2022-01-24 | 国立研究開発法人農業・食品産業技術総合研究機構 | 乳酸菌、乳酸菌発酵食品、血圧調整剤、及び乳酸菌発酵食品の製造方法 |
| CN115177641A (zh) * | 2021-04-07 | 2022-10-14 | 深圳奥萨制药有限公司 | 一种用于辅助控制高血压的组合物 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009138091A2 (en) * | 2008-05-13 | 2009-11-19 | OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus | Isolated microorganism strain lactobacillus plantarum tensia dsm 21380 as antimicrobial and antihypertensive probiotic, food product and composition comprising said microorganism and use of said microorganism for preparation of antihypertensive medicine and method for suppressing pathogens and non-starter lactobacilli in food product |
| WO2015067948A1 (en) * | 2013-11-05 | 2015-05-14 | Optibiotix Limited | Composition |
| WO2015067947A1 (en) * | 2013-11-05 | 2015-05-14 | Optibiotix Limited | Composition comprising lactobacillus plantarum |
| KR20150074518A (ko) * | 2013-12-24 | 2015-07-02 | 대상에프앤에프 주식회사 | 식물성유산균 발효액을 포함하는 당뇨 및 고혈압 예방 및 치료용 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0004124D0 (sv) | 2000-11-10 | 2000-11-10 | Probi Ab | New use |
| CN100370019C (zh) * | 2006-04-21 | 2008-02-20 | 江南大学 | 一种具有抗高血压作用的植物乳杆菌cw006 |
| KR101010913B1 (ko) | 2008-04-28 | 2011-01-26 | 주식회사 엔유씨전자 | 항고혈압활성 락토바실러스 플란타룸 및 이를 포함하는 발효물 |
| BG66608B1 (bg) | 2011-05-04 | 2017-10-16 | "Ел Би Булгарикум" ЕАД | Полибактериален пробиотичен препарат |
| KR101343410B1 (ko) | 2011-05-06 | 2013-12-20 | 충남대학교산학협력단 | 인삼 발효능을 갖는 신규 락토바실러스 플랜타럼 ｃｒｎｂ―２２ 〔ｋｃｔｃ１１９３１ ｂｐ〕균주 및 이를 이용한 사포닌 전환 방법 |
| CN102994420B (zh) | 2012-11-09 | 2014-08-20 | 黑龙江八一农垦大学 | 一株具有ace抑制活性的耐低温乳酸菌 |
| CN103598594B (zh) * | 2013-10-28 | 2015-05-20 | 天津科技大学 | 植物乳杆菌在降血脂和辅助减肥方面的应用 |
-
2015
- 2015-11-02 GB GBGB1519327.9A patent/GB201519327D0/en not_active Ceased
-
2016
- 2016-11-02 JP JP2018517278A patent/JP6867378B2/ja active Active
- 2016-11-02 WO PCT/GB2016/053390 patent/WO2017077286A1/en not_active Ceased
- 2016-11-02 CA CA3001539A patent/CA3001539A1/en active Pending
- 2016-11-02 EP EP16794395.0A patent/EP3370747B1/en active Active
- 2016-11-02 AU AU2016348841A patent/AU2016348841B2/en active Active
- 2016-11-02 US US15/764,994 patent/US11413317B2/en active Active
-
2022
- 2022-07-20 US US17/869,433 patent/US11903979B2/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009138091A2 (en) * | 2008-05-13 | 2009-11-19 | OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus | Isolated microorganism strain lactobacillus plantarum tensia dsm 21380 as antimicrobial and antihypertensive probiotic, food product and composition comprising said microorganism and use of said microorganism for preparation of antihypertensive medicine and method for suppressing pathogens and non-starter lactobacilli in food product |
| WO2015067948A1 (en) * | 2013-11-05 | 2015-05-14 | Optibiotix Limited | Composition |
| WO2015067947A1 (en) * | 2013-11-05 | 2015-05-14 | Optibiotix Limited | Composition comprising lactobacillus plantarum |
| KR20150074518A (ko) * | 2013-12-24 | 2015-07-02 | 대상에프앤에프 주식회사 | 식물성유산균 발효액을 포함하는 당뇨 및 고혈압 예방 및 치료용 조성물 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP6867378B2 (ja) | 2021-04-28 |
| AU2016348841A1 (en) | 2018-04-26 |
| US20180289749A1 (en) | 2018-10-11 |
| WO2017077286A1 (en) | 2017-05-11 |
| US20220347231A1 (en) | 2022-11-03 |
| GB201519327D0 (en) | 2015-12-16 |
| EP3370747B1 (en) | 2020-05-06 |
| US11413317B2 (en) | 2022-08-16 |
| US11903979B2 (en) | 2024-02-20 |
| EP3370747A1 (en) | 2018-09-12 |
| JP2018535940A (ja) | 2018-12-06 |
| CA3001539A1 (en) | 2017-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11903979B2 (en) | Composition comprising Lactobacillus plantarum 2830 (ECGC 13110402) | |
| DE69929321T2 (de) | Erfahren zür verringerung von cholesterin mit bacillus coagulans sporen, systeme un zusammensetzungen | |
| US6811786B1 (en) | Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions | |
| US20250025522A1 (en) | Composition | |
| US10898528B2 (en) | Composition comprising Lactobacillus plantarum 2830 (ECGC 13110402) | |
| KR20190090409A (ko) | 항비만 효과를 갖는 락토바실러스 플란타룸 kc3 균주 및 이의 용도 | |
| KR20190090407A (ko) | 항비만 효과를 갖는 락토바실러스 플란타룸 k10 균주 및 이의 용도 | |
| KR20040041026A (ko) | 알파-글루코시다제 및 알파-아밀라제 억제제를 함유하는영양 보충제 | |
| KR20200022660A (ko) | 혼합 추출물을 포함하는 지방간, 고지혈증 또는 비만 예방 또는 치료용 조성물 | |
| US20230404970A1 (en) | Direct delivery of vitamins to rebalance gut microbiome after exposure to antibiotics | |
| KR20190077715A (ko) | 항비만 효과를 갖는 락토바실러스 플란타룸 k259 균주 및 이의 용도 | |
| WO2022091023A1 (en) | Combination of active ingredients, compositions containing it and their use to sustain and strengthen the immune system | |
| AU2003236417B2 (en) | Methods For Reducing Cholesterol Using Bacillus Coagulans Spores, Systems And Compositions | |
| CA2808120A1 (en) | Two-phase preparation and use thereof for the treatment of herpes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1 | Assignment before grant (sect. 113) |
Owner name: PROBIOTIX HEALTH LIMITED Free format text: FORMER APPLICANT(S): OPTIBIOTIX LTD |
|
| FGA | Letters patent sealed or granted (standard patent) |